November 7, 2019
MEDx (Suzhou) and Lucence Partner to Co-Develop Cutting-Edge Cancer-Care Tests
SUZHOU, China–(BUSINESS WIRE)–MEDx (Suzhou) Translational Medicine, and Singapore-based Lucence – a leading genomic medicine company – today announced an agreement…